Guys,Further to above, EIF is developing supercritical fluid...

Guys,

Further to above,
EIF is developing supercritical fluid technology which in laymans terms reengineers drug particules which enhances delivery into the human body and optimises their effects.
Apparently they have succesfully applied this technology to insulin to dramatically increase its effectiveness.
These trails are preclinical so long way to go yet but what I like about this little baby is there revenue leadtimes (if technology is succesful) is much shorter than biotechs developing actual drugs.
SCF is not a drug as such but a delivery process.

Anyway do your DD.

Rob